A Randomized Phase III Study of Neoadjuvant Chemotherapy Followed by Surgery Versus Surgery Alone for Patients with High-Risk Retroperitoneal Sarcoma (STRASS2)
Ann Surg Oncol. 2023 May 11. doi: 10.1245/s10434-023-13500-9. Online ahead of print.NO ABSTRACTPMID:37170037 | DOI:10.1245/s10434-023-13500-9
Source: Ann Oncol - Category: Cancer & Oncology Authors: Jacob Lambdin Carrie Ryan Stephanie Gregory Kenneth Cardona Jonathan M Hernandez Winan J van Houdt Alessandro Gronchi Source Type: research
More News: Cancer & Oncology | Chemotherapy | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Sarcomas | Study